Featured
Hysterectomy, Oophorectomy Linked to Higher Diabetes Risk in Women
Home Air Oct 29, 2026
Home Air Oct 28, 2026
Toxin Watch Oct 27, 2026
Women undergoing both hysterectomy and oophorectomy face a 23% higher risk of type 2 diabetes,...
New guidelines for women's heart health issued to address the deadliest threat to American women,...
Stress-driven cravings contribute to weight gain, as revealed by a recent study on psychological distress...
Read our latest Mold Alerts articles.
Oral JAK inhibitors significantly enhance hair regrowth in alopecia areata patients, offering promising treatment options.
New CT methods predict fibrosis progression and drug effects, offering insights for patients with progressive...
New treatment approved for lung cancer patients with ROS1-positive non–small cell lung cancer.
Women undergoing both hysterectomy and oophorectomy face a 23% higher risk of type 2 diabetes, according to a long-term French study.
Women undergoing both hysterectomy and oophorectomy face a 23% higher risk of type 2 diabetes, according to a long-term French...
New guidelines for women's heart health issued to address the deadliest threat to American women, heart disease, which causes over...
Women's risk of autoimmune conditions may increase with age due to cellular aging, a new study finds, offering a biological...
Stress-driven cravings contribute to weight gain, as revealed by a recent study on psychological distress and food choices.
Pomegranate extract may improve skin elasticity by modulating gut microbes, according to a 12-week study of 64 women taking 367...
Cancer survivors with loneliness face nearly three times the risk of depression, reveals a study of over 70,000 adults using...
A new study of nearly half a million people suggests that drinking black tea may be linked to a lower...
A study of over 22,000 people shows walking about 8,000 steps daily may protect the brain from dementia, Parkinson’s disease...
Pharmacists' role in ATTR-CM care significantly improves patient outcomes through targeted interventions, as shown in a recent study.
The FDA just approved dostarlimab-gxly (Jemperli) as the first immunotherapy for advanced rectal cancer in patients with dMMR/MSI-H tumors, offering...